News

Our latest press releases, media appearances and topical commentary.





News
09 April 2019
Unrivalled imaging capabilities now available to accelerate UK drug development

Medicines Discovery Catapult integrates Alderley Park’s imaging services and expertise, further enhancing pre-clinical imaging capabilities.





News
04 February 2019
EPSRC announces 75 new Centres for Doctoral Training

The Engineering and Physical Sciences Research Council (EPSRC) has awarded a total of £446 million in funding for 75 new Centres for Doctoral Training (CDTs).


News
08 January 2019
NHS Long Term Plan: making the NHS fit for the future

NHS launched it’s Long Term Plan.


News
05 December 2018
£1.3 billion investment in UK economy as UK Government publishes second Life Sciences Sector Deal

Launch of the UK Governments’ second Life Sciences Sector Deal.


News
09 November 2018
Research Showcase launches new collaboration to accelerate translation of more predictive research models in drug discovery

Medicines Discovery Catapult and the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs) announce strategic collaboration.


News
07 November 2018
New collaboration will advance human-based drug evaluation

Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool announce strategic collaboration.


News
05 November 2018
Dr Peter Simpson takes part in debate around the North West “new golden triangle”

CSO, Dr Peter Simpson, took part in Insider Media’s New Golden Triangle breakfast event at Alderley Park.


News
29 October 2018
Funding for Artificial Intelligence boosted by autumn budget

Chancellor Philip Hammond has unveiled significant investment to advance artificial intelligence (AI) and data science in the UK.


News
23 October 2018
£215 million additional investment for UK innovation centres

The UK Government has announced a £55m five-year investment in Medicines Discovery Catapult.


News
22 October 2018
Overcoming bottlenecks in early drug discovery with the power of sound

Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry.






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult